Form 4: BlackRock Increases Stake in BlackRock ESG Capital Allocation Term Trust

BlackRock, Inc. reports the acquisition of 101,600 common shares of BlackRock ESG Capital Allocation Term Trust (ECAT) at a weighted average price of $16.21 per share.

Summary

• On March 19, 2025, BlackRock, Inc. acquired 101,600 common shares of BlackRock ESG Capital Allocation Term Trust (ECAT).
• The shares were purchased at a weighted average price of $16.21 per share, with individual prices ranging from $16.11 to $16.29.
• Following the transaction, BlackRock's direct holdings in ECAT increased to 973,600 shares.
• BlackRock Financial Management, Inc., a wholly-owned subsidiary of BlackRock, Inc., also holds 5,000 common shares indirectly.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a transaction. The increased stake could be seen as slightly positive, but it's not a strong signal.

Positives

• Increased investment by BlackRock in ECAT may signal confidence in the fund's performance or strategy.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders or entities holding more than 10% of a company's shares. This filing indicates BlackRock's ongoing investment activity in the BlackRock ESG Capital Allocation Term Trust.

Stakeholder Impact

• The increased stake by BlackRock could be viewed positively by shareholders of ECAT.

Key Dates

Keywords

BlackRock, ECAT, BlackRock ESG Capital Allocation Term Trust, share purchase, beneficial ownership, Form 4, investment